R&D News | pharmaphorum

News

Electra banks $183m for sHLH drug, and other biofinancings

Our round-up of recent biotech financings includes a big round for Electra, with Hemab, Zag Bio, Elevara, Expedition, and Curve also adding new funds.

News

Thermo bids $8.9bn for clinical trial data firm Clario

Thermo Fisher Scientific has signed a deal to acquire Clario for nearly $8.9bn in cash in a major expansion of its clinical research capabilities.

News

FDA plan will cut testing requirements for biosimilars

The FDA has proposed a radical change to the regulatory requirements for bringing biosimilar medicines to market as a way to cut US drug prices.

News

Novo tries to push Pfizer aside with $9bn bid for Metsera

Novo Nordisk has launched an audacious bid to elope with weight-loss therapy developer Metsera, before it can go ahead with a marriage to Pfizer.

News

MSD, Eisai abandon combination trial in liver cancer

MSD and Eisai's oncology partnership has had mixed fortunes this week, with a disappointment in liver cancer and encouraging data in kidney cancer.

News

BridgeBio two for two as rare disease drug aces ph3 trial

BridgeBio's week just went from great to superb, as it reports a second positive topline result in a pivotal trial of a late-stage pipeline drug.

Electra banks $183m for sHLH drug, and other biofinancings

Thermo bids $8.9bn for clinical trial data firm Clario

FDA plan will cut testing requirements for biosimilars

Novo tries to push Pfizer aside with $9bn bid for Metsera

MSD, Eisai abandon combination trial in liver cancer

BridgeBio two for two as rare disease drug aces ph3 trial

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

News

Editor's Picks